Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.
about
Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsDevelopments in the identification of glycan biomarkers for the detection of cancerSerum glycoprotein-derived N- and O-linked glycans as cancer biomarkersPurification of derivatized oligosaccharides by solid phase extraction for glycomic analysisMicrofluidic chip-based technologies: emerging platforms for cancer diagnosis.Advances in coupling microfluidic chips to mass spectrometry.Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure.High-mannose glycans are elevated during breast cancer progressionComparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serumPolysialylated N-glycans identified in human serum through combined developments in sample preparation, separations, and electrospray ionization-mass spectrometry.Multiple precursor ion scanning of gangliosides and sulfatides with a reversed-phase microfluidic chip and quadrupole time-of-flight mass spectrometryNovel data analysis tool for semiquantitative LC-MS-MS2 profiling of N-glycans.Sub 2-μm macroporous silica particles derivatized for enhanced lectin affinity enrichment of glycoproteinsThe glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery.Hemelipoglycoprotein from the ornate sheep tick, Dermacentor marginatus: structural and functional characterization.The sweet and sour of serological glycoprotein tumor biomarker quantification.Glycomic profiling of tissue sections by LC-MSGlycoPep Detector: a tool for assigning mass spectrometry data of N-linked glycopeptides on the basis of their electron transfer dissociation spectraStructural glycomic analyses at high sensitivity: a decade of progressGlycomic analysis by glycoprotein immobilization for glycan extraction and liquid chromatography on microfluidic chip.2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange fractionation and hydrophilic interaction UPLC reveals long poly-N-acetyl lactosamine extensions.Sialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobulin G N-glycans of ovarian cancer patients.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.Sample preparation for mass spectrometric analysis of human serum N-glycans using hydrophilic interaction chromatography-based solid phase extraction.Solid-phase methylamidation for sialoglycomics by MALDI-MS.Protein biomarkers for the early detection of breast cancer.Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography.N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteinsStructural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis.Isomeric complexity of glycosylation documented by MSn.Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins.Integrated Microfluidic Lectin Barcode Platform for High-Performance Focused Glycomic Profiling.Analytical glycobiology at high sensitivity: current approaches and directionsChip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analysesSite-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinomaIdentifying cancer biomarkers by mass spectrometry-based glycomicsDefining putative glycan cancer biomarkers by MS.Glycomic Alterations in the Highly-abundant and Lesser-abundant Blood Serum Protein Fractions for Patients Diagnosed with Hepatocellular CarcinomaResolving Isomeric Glycopeptide Glycoforms with Hydrophilic Interaction Chromatography (HILIC).
P2860
Q26822552-2D609E37-5086-4D51-9B95-013EBCDB5088Q27026715-AE732497-82BA-47DC-810B-D9A4FCA5DDCEQ28079101-10DFA8F2-BDB7-43D5-9229-166B89749690Q28542008-CD6AB0ED-361A-4291-8496-3D7BFC40C86BQ30446276-1006910D-FDC1-4A6B-862C-AEB5411ECBD7Q31147615-5B1912F0-F7AF-4726-A0AE-CECC1A351489Q33456015-B0C166EB-489A-48FE-BF37-86CCD8ED4349Q33753523-EBCDB35B-A66E-4F23-BDDB-8CBAB8749ADAQ34074809-74205B18-8E47-4BC4-9955-15A2BB430784Q34120306-ADEF1FE9-DC7F-4A9F-9042-D203FCBDDD73Q34304073-9FE0E355-AE17-4564-8F31-2E8D11515A46Q34307304-E4EF8E9D-B38C-49C6-AC1E-67C571261688Q34320236-B95AFF11-1B94-454D-90CA-01AB5405D5C7Q34383959-80238650-8901-4777-AE62-2D5F4E42F3A9Q34499967-E6616049-AB92-4751-8884-F15DE628FBCAQ34580285-F9634698-12DF-4418-B267-34D618EBF53DQ34601075-F259206A-4A09-4698-8329-1276A1D1AC8DQ34627486-818A78B0-B065-44FE-A681-750E2C88DEA0Q34656853-CCE9B7BA-A9CA-492C-9296-91C4D7205FA3Q35013214-D7CA8D10-21BF-4D1B-8099-0CE76930B5C4Q35017132-7A51F724-341A-44A4-B7EC-6C00A43B5B56Q35165824-EC7357BE-1C2B-4C1D-8668-7E7CE10F6475Q35174495-FD9A9B98-A6EB-4C84-ABC3-E4C705A14FC0Q35213998-3D149CD0-EE67-44EA-B896-D9C9C01D862DQ35217800-9AF70429-D3BA-4433-98E9-1CFE3487F82BQ35367572-3DF19D12-F5AA-4ABE-B875-9889F6878B7DQ35874074-A035F9CC-864B-4953-8BCA-C4405421B7BEQ35874750-7B60F4A6-8101-4333-8CFB-F48F58C4205FQ36089872-A4CB048B-FF12-48B3-AD8A-F0DAACB96D9DQ36098576-4C385EFC-2FF9-493F-BD57-CB5A3DA71A44Q36186390-173F5A6C-E3CF-4408-A1D5-2A1DEF75162BQ36362594-77443D8A-2547-47E0-9479-20B55CF0AF09Q36528533-D8A9A215-9A5D-428C-95A6-31585C2F0B37Q36651493-83ABE9B8-3064-4BE4-8F2C-0917D610EA0CQ36808014-770EAE40-BC17-44AF-A58F-D439F26B0754Q36832489-735DA9D8-CBFC-4BF4-962C-4C9EAC9BFE85Q36904006-7EBB4AF9-2082-48C9-996A-5676577F8B13Q36904030-3C9231AD-A44C-46FA-8D04-178FB13666FEQ36936153-39878634-5A33-4A95-9EBD-5B8BA20F6643Q37149694-C84A2D91-A1CC-4557-AC22-F0234B91179C
P2860
Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Chip-based reversed-phase liqu ...... or cancer-biomarker discovery.
@ast
Chip-based reversed-phase liqu ...... or cancer-biomarker discovery.
@en
Chip-based reversed-phase liqu ...... or cancer-biomarker discovery.
@nl
type
label
Chip-based reversed-phase liqu ...... or cancer-biomarker discovery.
@ast
Chip-based reversed-phase liqu ...... or cancer-biomarker discovery.
@en
Chip-based reversed-phase liqu ...... or cancer-biomarker discovery.
@nl
prefLabel
Chip-based reversed-phase liqu ...... or cancer-biomarker discovery.
@ast
Chip-based reversed-phase liqu ...... or cancer-biomarker discovery.
@en
Chip-based reversed-phase liqu ...... or cancer-biomarker discovery.
@nl
P2093
P2860
P356
P1433
P1476
Chip-based reversed-phase liqu ...... for cancer-biomarker discovery
@en
P2093
Milan Madera
Milos V Novotny
William R Alley
P2860
P304
P356
10.1021/AC100131E
P407
P577
2010-06-01T00:00:00Z